AdvaMed Hosts Demo Day Showcasing Innovative AI Imaging Technologies for Congressional Staff Following RSRT Fly-in

AdvaMed recently hosted an “AI Demo Day” on Capitol Hill, where a number of medical imaging innovators had the opportunity to showcase some of the latest artificial intelligence (AI) technologies to members of Congress and their staff.

Featuring imaging technologies from companies such as Siemens Healthineers and Philips, the event served to drive home the enormous potential that AI medical imaging has for the future of patient care and the need for the Centers for Medicare and Medicaid Services (CMS) to ensure patient access by implementing a payment pathway for AI-enabled medical technology.

AdvaMed’s AI Demo Day follows a letter sent by Senate AI Caucus Chairs, Senators Martin Heinrich (NM) and Mike Rounds (SD), along with Senators Marsha Blackburn (TN) and Todd Young (IN), urging CMS to develop a formal payment pathway for AI-enabled medical devices, linked here.

 Only about 10 AI/ML medical device technologies are currently reimbursed by Medicare. With patients, providers, and lawmakers embracing AI-enabled medical devices, RSRT hopes that these cutting-edge, innovations will be accessible to all patients. This will only happen if federal policymakers establish Medicare reimbursement pathways for these technologies.

To read AdvaMed’s press release on AI Demo Day, click here.

More Articles

WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

January 27, 2022

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to…

Read More

Our New Year’s Resolution: Ensure Safe Servicing

January 4, 2022

As we enter the new year, it’s time to set our resolutions for 2022. Here at Right Scan…

Read More

Bruce’s Story: A PET Scan Found My Recurrent Prostate Cancer

November 29, 2021

In 2018, I was diagnosed with prostate cancer. My doctors were able to surgically remove my prostate, and…

Read More

Support the FIND Act to Increase Access to Innovative Diagnostics

August 24, 2021

Through exciting innovations in diagnostic radiopharmaceuticals, doctors are finding new ways to diagnose and monitor conditions such as…

Read More